Industry Expertise

Healthcare

The right prescription for growth

With governments experiencing resource constraints, payers consolidating, and technology rapidly expanding, healthcare companies are competing to create the care models of the future in both emerging and developed markets. The opportunities for private industry are vast, but choosing the right market segments, payers, and patients to commercialize your therapeutics, devices, and services has never been more crucial.

Ensure that your science and intellectual property prevail in complex markets with a multidisciplinary approach that blends macro insights, payer and patient intelligence, competitive awareness, and channel strategies.

Who We Work With

DuckerFrontier serves a range of executives in the healthcare industry, from the companies that develop the pharmaceuticals and medical technology to the clinics and hospitals that use them. Our clients include firms on the cutting edge of pharmaceuticals, biopharmaceuticals, medical devices, and diagnostics; payers; hospital systems; and private equity.

What We Do

We’ve got our finger on the pulse of the healthcare industry. In this fast-changing field, DuckerFrontier helps clients navigate new landscapes, get their innovations to market quickly, and discover new opportunities for growth. We help you:

  • Choose the right markets for growth

    We combine analysis and forecasting of macro trends, including government spending power and operating conditions in specific geographies, with evaluations of the segments to target in those geographies to provide a comprehensive view of market opportunity.

  • Address your market access challenges

    We provide a 360-degree assessment of the geographic and market-specific barriers you need to overcome to commercialize your therapeutics, including the regulatory environment, competitive landscape, patient/provider/payer insights, and channel options.

  • Build your niche in the value-based care evolution

    We provide industry benchmarks on the provision of value-added services around core therapeutics/devices and build strategies to help you protect and grow market share in an increasingly competitive, price-constrained environment.

  • Develop the optimal strategy for inorganic growth

    We help you make the right strategic choices in a rapidly consolidating industry by mapping acquisition targets and conducting due diligence, including your targets’ ability to achieve growth and market access goals.

  • Stay abreast of emerging trends

    We host the leading conferences for market research and competitive intelligence professionals in the pharmaceutical and healthcare industry, bringing together thought leaders and influencers from leading companies for interactive discussions.

Our Expertise by the Numbers

In the US, the adoption of value-based care payments is expected to reach

59% of healthcare payments

by 2020 (Aetna 2018 Healthcare Trends)

55 global healthcare clients,

including 70% of the largest 20 Fortune 500 pharmaceutical and medical device companies

93%

of multinational pharmaceutical companies do not have value-added services that contribute to profitability growth; the figure is 46% for medical device multinationals (DuckerFrontier healthcare executive survey, 2018)

190

countries covered with data, analysis, consulting engagements, expert insights, and reports

150

client projects completed in pharmaceuticals and medical devices in the last four years

Leadership

Emily-Scott200x200
Emily Scott

Managing Director

Stephen Majors

Commercial Director

Alec Lee
Alec Lee

Practice Leader

Work With DuckerFrontier

Ready to deliver better outcomes for your business with us by your side?

Get Started